Cover Image
市場調查報告書

冠狀動脈栓塞:全球臨床實驗回顧(2011年下半年)

Coronary Thrombosis Global Clinical Trials Review, H2, 2017

出版商 GlobalData 商品編碼 217237
出版日期 內容資訊 英文 38 Pages
訂單完成後即時交付
價格
Back to Top
冠狀動脈栓塞:全球臨床實驗回顧(2011年下半年) Coronary Thrombosis Global Clinical Trials Review, H2, 2017
出版日期: 2017年07月19日 內容資訊: 英文 38 Pages
簡介

本報告提供冠狀動脈栓塞治療藥物的臨床實驗資料,彙整各國的趨勢,臨床實驗數,全球各臨床實驗中心的募集情形等資料,為您概述為以下內容。

目錄

簡介

  • 冠狀動脈栓塞
  • 關於本報告

不同地區的臨床實驗

  • 各國臨床實驗
    • 亞太地區的前幾名國家
    • 歐洲的前五名國家
    • 北美前幾名國家

G7各國的臨床實驗

各進展狀況:G7各國的臨床實驗

各方面的臨床實驗

各進展狀況的臨床實驗

尚未完成的臨床實驗

一定期間內採用的實驗人數

有潛力的贊助商

有潛力的藥劑比較

臨床實驗簡介

  • 臨床實驗概要:前幾名企業
    • Abbott Laboratories
  • 臨床實驗概要:前幾名大學·研究所·醫院
    • Scripps Health
    • Minneapolis Medical Research Foundation
    • Heart Center Bad Krozingen
    • University Hospital Gasthuisberg
    • University of Zurich
    • Samsung Medical Center
    • The University of Hong Kong
    • University Hospital Basel
    • Assistance Publique - Hopitaux de Paris

5個主要的臨床簡介

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC4342CTIDB

GlobalData's clinical trial report, "Coronary Thrombosis Global Clinical Trials Review, H2, 2017" provides an overview of Coronary Thrombosis clinical trials scenario. This report provides top line data relating to the clinical trials on Coronary Thrombosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 3
  • Report Guidance 4
  • GlobalData Clinical Trials Report Coverage 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Countries Contributing to Clinical Trials in Central and South America 13
  • Clinical Trials by G7 Countries: Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 16
  • Clinical Trials in G7 Countries by Trial Status 17
  • Clinical Trials by E7 Countries: Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials 18
  • Clinical Trials by Phase in E7 Countries 20
  • Clinical Trials in E7 Countries by Trial Status 21
  • Clinical Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Clinical Trials by End Point Status 25
  • Clinical Trials by Sponsor Type 26
  • Prominent Sponsors 27
  • Top Companies Participating in Coronary Thrombosis Therapeutics Clinical Trials 28
  • Prominent Drugs 29
  • Clinical Trial Profile Snapshots 30

Appendix 36

  • Abbreviations 36
  • Definitions 36
  • Research Methodology 37
  • Secondary Research 37
  • About GlobalData 38
  • Contact Us 38
  • Source 38

List of Tables

List of Tables

  • Coronary Thrombosis Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Coronary Thrombosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 10
  • Coronary Thrombosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
  • Coronary Thrombosis Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
  • Coronary Thrombosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 13
  • Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 15
  • Coronary Thrombosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
  • Coronary Thrombosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
  • Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials, E7 Countries (%), 2017* 19
  • Coronary Thrombosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
  • Coronary Thrombosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials by Phase, 2017* 22
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
  • Coronary Thrombosis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Coronary Thrombosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26
  • Coronary Thrombosis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
  • Coronary Thrombosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
  • Coronary Thrombosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29

List of Figures

List of Figures

  • Coronary Thrombosis Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Coronary Thrombosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017* 10
  • Coronary Thrombosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
  • Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 14
  • Coronary Thrombosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
  • Coronary Thrombosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
  • Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials, E7 Countries (%), 2017* 18
  • Coronary Thrombosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
  • Coronary Thrombosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials by Phase (%), 2017* 22
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
  • Coronary Thrombosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 26
  • Coronary Thrombosis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
  • Coronary Thrombosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
  • Coronary Thrombosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29
  • GlobalData Methodology 37
Back to Top